Clinical Trials
2 trialsNCT05142241 2025-11-18
Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT05053854 2025-02-20
PARLuNET
Peter MacCallum Cancer Centre, Australia
Phase 1 Recruiting